Vorapaxar (Zontivity) for the Prevention of Thrombotic Cardiovascular Events.
University of Virginia Health System, Charlottesville, VA, USA.
Kathleen A
KA
Barry
University of Virginia Health System, Charlottesville, VA, USA.
Nicholas J
NJ
Somerville
D006470:Hemorrhage / Q000139:chemically induced / Q000517:prevention & control; D006801:Humans; D007783:Lactones / Q000494:pharmacology*; D009203:Myocardial Infarction / Q000209:etiology / Q000517:prevention & control*; D018579:Patient Selection; D058729:Peripheral Arterial Disease / Q000209:etiology / Q000517:prevention & control*; D010975:Platelet Aggregation Inhibitors / Q000494:pharmacology*; D011725:Pyridines / Q000494:pharmacology*; D016032:Randomized Controlled Trials as Topic; D013927:Thrombosis / Q000150:complications / Q000517:prevention & control*
D007783:Lactones; D010975:Platelet Aggregation Inhibitors; D011725:Pyridines; C530299:vorapaxar